**Core Concept**: Losartan is a selective angiotensin II type 1 (AT1) receptor blocker used as an antihypertensive drug. It belongs to the class of medications known as angiotensin II receptor antagonists (ARBs) and acts by blocking the effects of angiotensin II, a potent vasoconstrictor and aldosterone-stimulating hormone.

**Why the Correct Answer is Right:** Losartan has a favorable profile due to its selective action on the AT1 receptor, which is responsible for vasoconstriction, aldosterone secretion, and sodium retention. Since it does not block the AT2 receptor, losartan does not cause the side effects typically seen with ACE inhibitors (angiotensin converting enzyme inhibitors). ACE inhibitors, on the other hand, block both AT1 and AT2 receptors, leading to more severe side effects due to the blockade of AT2 receptor.

**Why Each Wrong Option is Incorrect:**

A. **Angiotensin II (AII):** Losartan blocks the AT1 receptor, which is the major effector receptor for angiotensin II. Hence, it does not lead to increased AII levels, and this option is incorrect.
B. **Increased aldosterone secretion:** Losartan does not block the AT2 receptor, which is responsible for aldosterone secretion. This option is incorrect.
C. **Hypotension:** Losartan is a selective antagonist, which means it only blocks the AT1 receptor, and does not cause hypotension. This option is incorrect.
D. **Hypertension:** Losartan is a selective antagonist, which means it only blocks the AT1 receptor, and does not cause hypertension. This option is incorrect.

**Clinical Pearl:** The clinical pearl from this question is the importance of understanding the pharmacology of specific drug classes and their mechanisms of action to predict potential side effects and therapeutic benefits. It highlights the need to consider the specific blockade of receptors and their downstream effects when assessing the potential side effects of medications.